FDA to pave clearer path for generic drugs

The FDA's new guidance aims to make it easier for generic firms to plan how they can copy complex drugs like epinephrine auto-injectors, which should ultimately lower pharmaceutical prices.

Read the full post at Modern Healthcare Breaking News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive